Literature DB >> 27038640

Prognosis of Low Normal Left Ventricular Ejection Fraction in an Asymptomatic Population-Based Adult Cohort: The Multiethnic Study of Atherosclerosis.

Joseph Yeboah1, Carlos J Rodriguez2, Waqas Qureshi3, Songtao Liu4, J Jeffrey Carr5, Joao A Lima6, W Gregory Hundley3, David M Herrington3.   

Abstract

BACKGROUND: Reduced left ventricular systolic function predicts worse outcomes. However, the optimal threshold for "normal" left ventricular ejection fraction (LVEF) is uncertain. In general, LVEF ≥ 55% is considered to be "normal" by guidelines, with a low normal designation for LVEF being 50%-55%. We assessed the prognosis of participants with low normal LVEF in the Multiethnic Study of Atherosclerosis. All participants were asymptomatic and had no known clinical cardiovascular disease at baseline. METHODS AND
RESULTS: A total of 4926 out of 6814 had LVEF assessed with the use of cardiac magnetic resonance imaging (MRI), had no significant valvular disease, did not have myocardial infarction during follow-up, had complete data, and were included in this analysis. A total of 83/4926 (1.7%) had LVEF < 50% (low LVEF) and 101/4926 (2.1%) had low normal LVEF. Cox proportional hazard and cubic spline analyses were used to evaluate the association between LVEF category and 10 years of adjudicated incident congestive heart failure (CHF) and all-cause mortality adjusting for (model 1) age, sex, and race and (model 2) model 1 and diabetes mellitus, smoking, systolic blood pressure (BP), BP medications, body mass index, estimated glomerular filtration rate, low-density lipoprotein, family history of coronary heart disease, educational status, and LV mass. Mean age was 61 ± 10 years, 47% were men, 35% were on BP medications, 9% had diabetes. After 10.2 years of follow-up, 109 (2.2%) had CHF and 427 (8.7%) died. Compared with normal LVEF (≥55%), low normal LVEF and low LVEF were associated with an increased risk for incident CHF during follow-up in our multivariable Cox models: hazard ratios (HRs) 3.64 (95% CI 1.76-7.52) and 9.52 (5.63-17.52), respectively. Unlike low LVEF, low normal LVEF was not associated with increased risk of death compared with normal LVEF in our fully adjusted models: HRs 3.03 (1.94-4.73) and 1.32 (0.72-2.41), respectively. In the adjusted spline analysis HR of LVEF 55% as reference, LVEF had a U-shape association of future CHF risk and LVEF.
CONCLUSION: Low normal LVEF is as prevalent as low LVEF in asymptomatic community-dwelling adults. We observed a gradient-response association between the 3 categories of LVEF (low, low normal, and normal) and incident CHF but not for all-cause death.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Low normal left ventricular ejection fraction; congestive heart failure; death; prevalence; prognosis

Mesh:

Year:  2016        PMID: 27038640      PMCID: PMC5036995          DOI: 10.1016/j.cardfail.2016.03.013

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  17 in total

Review 1.  Mechanisms and models in heart failure: the biomechanical model and beyond.

Authors:  Douglas L Mann; Michael R Bristow
Journal:  Circulation       Date:  2005-05-31       Impact factor: 29.690

2.  2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.

Authors:  Clyde W Yancy; Mariell Jessup; Biykem Bozkurt; Javed Butler; Donald E Casey; Mark H Drazner; Gregg C Fonarow; Stephen A Geraci; Tamara Horwich; James L Januzzi; Maryl R Johnson; Edward K Kasper; Wayne C Levy; Frederick A Masoudi; Patrick E McBride; John J V McMurray; Judith E Mitchell; Pamela N Peterson; Barbara Riegel; Flora Sam; Lynne W Stevenson; W H Wilson Tang; Emily J Tsai; Bruce L Wilkoff
Journal:  Circulation       Date:  2013-06-05       Impact factor: 29.690

3.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

4.  ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure).

Authors:  S A Hunt; D W Baker; M H Chin; M P Cinquegrani; A M Feldman; G S Francis; T G Ganiats; S Goldstein; G Gregoratos; M L Jessup; R J Noble; M Packer; M A Silver; L W Stevenson; R J Gibbons; E M Antman; J S Alpert; D P Faxon; V Fuster; A K Jacobs; L F Hiratzka; R O Russell; S C Smith
Journal:  J Am Coll Cardiol       Date:  2001-12       Impact factor: 24.094

5.  Cardiovascular function in multi-ethnic study of atherosclerosis: normal values by age, sex, and ethnicity.

Authors:  Shunsuke Natori; Shenghan Lai; J Paul Finn; Antoinette S Gomes; W Gregory Hundley; Michael Jerosch-Herold; Gregory Pearson; Shantanu Sinha; Andrew Arai; Joao A C Lima; David A Bluemke
Journal:  AJR Am J Roentgenol       Date:  2006-06       Impact factor: 3.959

Review 6.  Heart failure in the ethnic minorities.

Authors:  Gordon W Moe; Jack Tu
Journal:  Curr Opin Cardiol       Date:  2010-03       Impact factor: 2.161

7.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

Authors:  M A Pfeffer; E Braunwald; L A Moyé; L Basta; E J Brown; T E Cuddy; B R Davis; E M Geltman; S Goldman; G C Flaker
Journal:  N Engl J Med       Date:  1992-09-03       Impact factor: 91.245

8.  Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions.

Authors:  S Yusuf; B Pitt; C E Davis; W B Hood; J N Cohn
Journal:  N Engl J Med       Date:  1992-09-03       Impact factor: 91.245

9.  Prognosis of individuals with asymptomatic left ventricular systolic dysfunction in the multi-ethnic study of atherosclerosis (MESA).

Authors:  Joseph Yeboah; Carlos J Rodriguez; Brandon Stacey; Joao A Lima; Songtao Liu; J Jeffrey Carr; W Gregory Hundley; David M Herrington
Journal:  Circulation       Date:  2012-11-02       Impact factor: 29.690

10.  Multi-Ethnic Study of Atherosclerosis: objectives and design.

Authors:  Diane E Bild; David A Bluemke; Gregory L Burke; Robert Detrano; Ana V Diez Roux; Aaron R Folsom; Philip Greenland; David R Jacob; Richard Kronmal; Kiang Liu; Jennifer Clark Nelson; Daniel O'Leary; Mohammed F Saad; Steven Shea; Moyses Szklo; Russell P Tracy
Journal:  Am J Epidemiol       Date:  2002-11-01       Impact factor: 4.897

View more
  5 in total

1.  Predicting deterioration of ventricular function in patients with repaired tetralogy of Fallot using machine learning.

Authors:  Manar D Samad; Gregory J Wehner; Mohammad R Arbabshirani; Linyuan Jing; Andrew J Powell; Tal Geva; Christopher M Haggerty; Brandon K Fornwalt
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2018-07-01       Impact factor: 6.875

2.  Routinely reported ejection fraction and mortality in clinical practice: where does the nadir of risk lie?

Authors:  Gregory J Wehner; Linyuan Jing; Christopher M Haggerty; Jonathan D Suever; Joseph B Leader; Dustin N Hartzel; H Lester Kirchner; Joseph N A Manus; Nick James; Zina Ayar; Patrick Gladding; Christopher W Good; John G F Cleland; Brandon K Fornwalt
Journal:  Eur Heart J       Date:  2020-03-21       Impact factor: 29.983

3.  Left ventricular contractile performance and heart failure in patients with left ventricular ejection fraction more than 40.

Authors:  Shuichi Kitada; Yu Kawada; Satoshi Osaga; Marina Kato; Shohei Kikuchi; Kazuaki Wakami; Yoshihiro Seo; Nobuyuki Ohte
Journal:  Heart Vessels       Date:  2020-06-05       Impact factor: 2.037

4.  Sex-Related Differences in Mortality Following Admission for Acute Heart Failure Across the Left Ventricular Ejection Fraction Spectrum.

Authors:  Enrique Santas; Patricia Palau; Pau Llácer; Rafael de la Espriella; Gema Miñana; Gonzalo Núñez-Marín; Miguel Lorenzo; Raquel Heredia; Juan Sanchis; Francisco Javier Chorro; Antoni Bayés-Genís; Julio Núñez
Journal:  J Am Heart Assoc       Date:  2021-12-20       Impact factor: 6.106

5.  The Effect of Adiposity on Cardiovascular Function and Myocardial Fibrosis in Patients With Duchenne Muscular Dystrophy.

Authors:  Sarah E Henson; Sean M Lang; Philip R Khoury; Cuixia Tian; Meilan M Rutter; Elaine M Urbina; Thomas D Ryan; Michael D Taylor; Tarek Alsaied
Journal:  J Am Heart Assoc       Date:  2021-09-25       Impact factor: 5.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.